Venker Eric

Insider

President & Immunovant CEO

Trades at: ROIV· IMVT

30D 90D 1Y

Net shares · 365d

-5.2M

0 buy · 5.2M sell

Net value · 365d

-$97.2M

$0 in · $97.2M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 5.2M sell

Net buy / sell volume (all companies)

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions · open-market

Include grants & non-market

ROIV Sell·S
May 22, 26

President & Immunovant CEO · 10b5-1

$6.1M

200.0K sh · $30.27

Own -11%
ROIV Sell·S
Apr 20, 26

President & Immunovant CEO · 10b5-1

$5.9M

200.0K sh · $29.59

Own -11%
IMVT Sell·S
Apr 2, 26

Chief Executive Officer

$34.7K

1.4K sh · $24.60

Own -7%
IMVT Sell·S
Apr 2, 26

Chief Executive Officer

$308.2K

12.8K sh · $24.04

Own -38%
ROIV Sell·S
Mar 17, 26

President & Immunovant CEO · 10b5-1

$5.6M

200.0K sh · $28.24

Own -11%
ROIV Sell·S
Feb 13, 26

President & Immunovant CEO · 10b5-1

$5.3M

200.0K sh · $26.49

Own -11%
ROIV Sell·S
Jan 12, 26

President & Immunovant CEO · 10b5-1

$4.4M

200.0K sh · $21.92

Own -11%
ROIV Sell·S
Dec 24, 25

President & Immunovant CEO

$1.7M

75.0K sh · $22.53

Own -4%
ROIV Sell·S
Dec 23, 25

President & Immunovant CEO

$4.5M

200.0K sh · $22.45

Own -11%
ROIV Sell·S
Dec 9, 25

President & Immunovant CEO · 10b5-1

$4.2M

200.0K sh · $20.85

Own -12%
ROIV Sell·S
Nov 7, 25

President & Immunovant CEO · 10b5-1

$4.0M

200.0K sh · $20.22

Own -12%
ROIV Sell·S
Oct 17, 25

President & Immunovant CEO · 10b5-1

$2.0M

118.4K sh · $17.06

Own -7%
ROIV Sell·S
Oct 16, 25

President & Immunovant CEO · 10b5-1

$5.4M

318.3K sh · $17.05

Own -17%
ROIV Sell·S
Oct 15, 25

President & Immunovant CEO · 10b5-1

$7.0M

414.7K sh · $16.93

Own -22%
ROIV Sell·S
Oct 13, 25

President & Immunovant CEO · 10b5-1

$336.8K

20.7K sh · $16.25

Own -1%
ROIV Sell·S
Oct 9, 25

President & Immunovant CEO · 10b5-1

$1.7M

104.9K sh · $16.30

Own -7%
ROIV Sell·S
Oct 8, 25

President & Immunovant CEO · 10b5-1

$2.2M

138.6K sh · $16.20

Own -8%
ROIV Sell·S
Oct 7, 25

President & Immunovant CEO · 10b5-1

$5.7M

355.2K sh · $16.15

Own -19%
ROIV Sell·S
Oct 6, 25

President & Immunovant CEO · 10b5-1

$2.8M

171.4K sh · $16.34

Own -10%
ROIV Sell·S
Sep 23, 25

President & Immunovant CEO · 10b5-1

$9.1M

611.0K sh · $14.83

Own -29%
ROIV Sell·S
Sep 22, 25

President & Immunovant CEO · 10b5-1

$1.5M

100.0K sh · $15.01

Own -5%
ROIV Sell·S
Sep 22, 25

President & Immunovant CEO · 10b5-1

$4.7M

316.2K sh · $14.99

Own -12%
ROIV Sell·S
Sep 19, 25

President & Immunovant CEO · 10b5-1

$10.2M

683.8K sh · $14.95

Own -26%
ROIV Sell·S
Aug 20, 25

President & Immunovant CEO · 10b5-1

$1.2M

100.0K sh · $11.72

Own -6%
ROIV Sell·S
Jul 21, 25

President & Immunovant CEO · 10b5-1

$1.2M

100.0K sh · $11.52

Own -6%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 22, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$30.27	$6.1M
Apr 20, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$29.59	$5.9M
Apr 2, 2026	IMVT	Chief Executive Officer	Sell S	1.4K	-7%	$24.60	$34.7K
Apr 2, 2026	IMVT	Chief Executive Officer	Sell S	12.8K	-38%	$24.04	$308.2K
Mar 17, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$28.24	$5.6M
Feb 13, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$26.49	$5.3M
Jan 12, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$21.92	$4.4M
Dec 24, 2025	ROIV	President & Immunovant CEO	Sell S	75.0K	-4%	$22.53	$1.7M
Dec 23, 2025	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$22.45	$4.5M
Dec 9, 2025	ROIV	President & Immunovant CEO	Sell S	200.0K	-12%	$20.85	$4.2M
Nov 7, 2025	ROIV	President & Immunovant CEO	Sell S	200.0K	-12%	$20.22	$4.0M
Oct 17, 2025	ROIV	President & Immunovant CEO	Sell S	118.4K	-7%	$17.06	$2.0M
Oct 16, 2025	ROIV	President & Immunovant CEO	Sell S	318.3K	-17%	$17.05	$5.4M
Oct 15, 2025	ROIV	President & Immunovant CEO	Sell S	414.7K	-22%	$16.93	$7.0M
Oct 13, 2025	ROIV	President & Immunovant CEO	Sell S	20.7K	-1%	$16.25	$336.8K
Oct 9, 2025	ROIV	President & Immunovant CEO	Sell S	104.9K	-7%	$16.30	$1.7M
Oct 8, 2025	ROIV	President & Immunovant CEO	Sell S	138.6K	-8%	$16.20	$2.2M
Oct 7, 2025	ROIV	President & Immunovant CEO	Sell S	355.2K	-19%	$16.15	$5.7M
Oct 6, 2025	ROIV	President & Immunovant CEO	Sell S	171.4K	-10%	$16.34	$2.8M
Sep 23, 2025	ROIV	President & Immunovant CEO	Sell S	611.0K	-29%	$14.83	$9.1M
Sep 22, 2025	ROIV	President & Immunovant CEO	Sell S	100.0K	-5%	$15.01	$1.5M
Sep 22, 2025	ROIV	President & Immunovant CEO	Sell S	316.2K	-12%	$14.99	$4.7M
Sep 19, 2025	ROIV	President & Immunovant CEO	Sell S	683.8K	-26%	$14.95	$10.2M
Aug 20, 2025	ROIV	President & Immunovant CEO	Sell S	100.0K	-6%	$11.72	$1.2M
Jul 21, 2025	ROIV	President & Immunovant CEO	Sell S	100.0K	-6%	$11.52	$1.2M

About Venker Eric

This profile aggregates every SEC Form 4 insider transaction reported by Venker Eric across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.